CHRU de Brest ( Site 0272)

Brest, Finistere 29200

1 studies enrolling now · 1 studies all time

What they study most

Bladder Cancer

Studies at this site

• A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031) — Recruiting now